Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia

Time to Insurance Approval in Private and Public Payers Does Not Influence Survival in Patients Who Undergo Hematopoietic Cell Transplantation

(2016) Vijaya Raj Bhatt et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502

(2015) Steven M. Devine et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults

(2015) Yvette L. Kasamon et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989–2012

(2015) A G Dinmohamed et al.   LEUKEMIA

Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis

(2015) Jurjen Versluis et al.   Lancet Haematology

Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: A SEER database analysis

(2014) Andrew M. Brunner et al.   LEUKEMIA RESEARCH

Outcomes in Patients Age 70 or Older Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies

(2013) Andrew M. Brunner et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century

(2013) C Ustun et al.   BONE MARROW TRANSPLANTATION

Outcome of older patients with acute myeloid leukemia

(2013) Mya S. Thein et al.   CANCER

Frequency of Allogeneic Hematopoietic Cell Transplantation Among Patients With High- or Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission

(2013) Raya Mawad et al.   JOURNAL OF CLINICAL ONCOLOGY

Medicare Fee-for-Service Enrollees with Primary Acute Myeloid Leukemia: An Analysis of Treatment Patterns, Survival, and Healthcare Resource Utilization and Costs

(2013) Juliana Meyers et al.   Applied Health Economics and Health Policy

Practice variation in physician referral for allogeneic hematopoietic cell transplantation

(2012) J Pidala et al.   BONE MARROW TRANSPLANTATION

Survival for older patients with acute myeloid leukemia: a population-based study

(2012) B. Oran et al.   HAEMATOLOGICA

Reduced-Intensity Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: A Report from the SFGM-TC

(2011) Patrice Chevallier et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies

(2011) Mohamed L. Sorror et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: Hematologic Malignancy Outcomes Are Not Impaired in Advanced Age

(2010) John Koreth et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome

(2010) Brian L. McClune et al.   JOURNAL OF CLINICAL ONCOLOGY

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission

(2009) John Koreth et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION